已收盤 11-20 16:00:00 美东时间
-0.030
-11.36%
11月20日,EyePoint Pharmaceuticals Inc.(EYPT)收跌2.87%,报0.26美元,成交额93.33万美元,市值3006.14万...
11-20 08:42
EyePoint Pharmaceuticals ( ($EYPT) ) has shared an update. EyePoint, Inc.’s lea...
11-20 05:38
① 强生拟最高约33亿美元收购信达生物合作伙伴Ollin,其核心管线OLN324由信达研发后授权。Ib期随机头对头研究显示,DME患者中OLN324视网膜解剖改善优于罗氏Vabysmo; ②视网膜疾病治疗全球市场规模达150亿美元,国内外已有多家企业展开适应症管线布局。
11-17 09:29
11月17日,EyePoint Pharmaceuticals Inc.(EYPT)收涨0.52%,报0.31美元,成交额196.74万美元,市值2651.8...
11-17 08:41
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从39美元升至40美元;HC Wainwright & Co.:维持Fractyl Health"买入"评级,目标价从8美元升至24美元
11-16 20:14
Eyepoint Pharma (($EYPT)) has held its Q3 earnings call. Read on for the main h...
11-15 12:58
最新财报显示,EyePoint Pharmaceuticals Inc.2026财年第3季度实现: 营业收入:75.6万美元 同比:下降21.74% 净利润:...
11-15 01:00
Stifel analyst Annabel Samimy maintains EyePoint (NASDAQ:EYPT) with a Buy and lowers the price target from $6 to $5.
11-13 21:04
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www...
11-12 22:26
EyePoint, Inc. will participate in several conferences and scientific meetings in November and December 2026 to discuss its innovative therapeutics for retinal diseases, including presentations on pivotal Phase 3 trial results for EYP-1901 in Wet AMD and DME. The company will present at the Guggenheim 3rd Annual Healthcare Innovation Conference, Stifel 2026 Healthcare Conference, Jefferies 2026 Global Healthcare Conference in London, and UBS Glob...
11-06 12:00